Industry Insights

  1. How A New Cell Therapy Platform Helps Scale Up Manufacturing To Reach More Patients
    9/6/2018

    Cell therapy manufacturing has been a complex, challenging and costly process, but a new manufacturing solution seeks to change that

  2. The Big (Bio) Freeze
    9/4/2018

    Reproducible freezing and thawing is critical for successful cell therapies. GE Healthcare’s G. John Morris explains why.

  3. Industrializing Cell Therapy
    9/4/2018

    Insights on cell therapy manufacturing challenges and how to overcome them.

  4. An Overview Of ISCT 2018 In Montreal
    9/4/2018

    Once upon a time people wondered whether cell therapies would make it. Now, the industry is surging forward with new questions and even more creative solutions – takeaways from ISCT 2018, Montreal.

  5. Provocative Questions For CAR T Cell Therapy Scientists
    8/31/2018

    The FDA approval of two cell therapies is a major milestone on an exciting journey of discovery. What are some of the important questions still being explored?

  6. How A New Factory-In-A-Box Is Helping Scale Up Manufacturing Of Viral Vector Based Therapies To Reach More Patients
    8/31/2018

    Manufacturing viral vector-based therapies such as vaccines and gene and cell therapies is complex, but a new manufacturing solution helps solve those challenges.

  7. The Future Of Precision Medicine In China
    8/30/2018

    China is quickly becoming a world leader in biopharma, with rapid build-out of gene and cell therapy production capacity and a robust pipeline of drugs in development.